BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4020629)

  • 1. Protein binding of propisomide.
    Zini R; Barre J; Defer G; Jeanniot JP; Houin G; Tillement JP
    J Pharm Sci; 1985 May; 74(5):530-3. PubMed ID: 4020629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma protein binding of disopyramide by equilibrium dialysis and ultrafiltration.
    David BM; Tjokrosetio R; Ilett KF
    Ther Drug Monit; 1983; 5(1):81-6. PubMed ID: 6845403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of propisomide, a new antiarrhythmic agent, in biological samples by gas chromatography with a thermionic detector.
    Necciari J; Mery D; Sales Y; Berthet D; Cautreels W
    J Chromatogr; 1985 May; 341(1):202-7. PubMed ID: 4019687
    [No Abstract]   [Full Text] [Related]  

  • 4. Cicletanine binding to human plasma proteins and erythrocytes, a particular HSA-drug interaction.
    Zini R; Morin D; Jouenne P; Tillement JP
    Life Sci; 1988; 43(25):2103-15. PubMed ID: 3210902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum protein binding of noscapine: influence of a reversible hydrolysis.
    Karlsson MO; Dahlström B
    J Pharm Pharmacol; 1990 Feb; 42(2):140-3. PubMed ID: 1972403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid-chromatographic determination of propisomide and its mono-N-dealkylated metabolite in plasma and urine.
    Houin G; Jeanniot JP; Ledudal P; Barré J; Tillement JP
    Clin Chem; 1985 Jul; 31(7):1222-4. PubMed ID: 4006195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of unbound fraction of disopyramide in plasma: a comparison of equilibrium dialysis, ultrafiltration through dialysis membranes and ultrafree anticonvulsant drug filters.
    Norris RL; Ahokas JT; Ravenscroft PJ
    J Pharmacol Methods; 1982 Jan; 7(1):7-14. PubMed ID: 7070107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-protein-binding determination of stilbene glucoside using cloud-point extraction and comparison with ultrafiltration and equilibrium dialysis.
    Wang C; Wang Q; Yuan Z; Liu W; Gu J; Zhang L
    Drug Dev Ind Pharm; 2010 Mar; 36(3):307-14. PubMed ID: 19670965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The "ultra-free" ultrafiltration technique compared with equilibrium dialysis for determination of unbound thiopental concentrations in serum.
    Jung D; Mayersohn M; Perrier D
    Clin Chem; 1981 Jan; 27(1):166-8. PubMed ID: 7449102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin high-affinity binding to alpha-1-acid glycoprotein in human serum.
    Morin D; Simon N; Deprés-Brummer P; Lévi F; Tillement JP; Urien S
    Pharmacology; 1997 May; 54(5):271-5. PubMed ID: 9380773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tianeptine binding to human plasma proteins and plasma from patients with hepatic cirrhosis or renal failure.
    Zini R; Morin D; Salvadori C; Tillement JP
    Br J Clin Pharmacol; 1990 Jan; 29(1):9-18. PubMed ID: 2297464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences between blacks and whites in plasma protein binding of drugs.
    Johnson JA; Livingston TN
    Eur J Clin Pharmacol; 1997; 51(6):485-8. PubMed ID: 9112064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The acute changes in serum binding of disopyramide and flecainide after myocardial infarction.
    Caplin JL; Johnston A; Hamer J; Camm AJ
    Eur J Clin Pharmacol; 1985; 28(3):253-5. PubMed ID: 4007029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of theophylline in human serum determined by ultrafiltration and equilibrium dialysis.
    Brørs O; Sager G; Sandnes D; Jacobsen S
    Br J Clin Pharmacol; 1983 Apr; 15(4):393-7. PubMed ID: 6849773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of plasma protein binding for pharmacokinetics and pharmacodynamics of the γ-secretase inhibitor RO4929097.
    Wu J; Lorusso PM; Matherly LH; Li J
    Clin Cancer Res; 2012 Apr; 18(7):2066-79. PubMed ID: 22351688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prazosin binding to human alpha 1-acid glycoprotein (orosomucoid), human serum albumin, and human serum. Further characterization of the 'single drug binding site' of orosomucoid.
    Brunner F; Müller WE
    J Pharm Pharmacol; 1985 May; 37(5):305-9. PubMed ID: 2862237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein binding of tirilazad (U-74006) in human, Sprague-Dawley rat, beagle dog and cynomolgus monkey serum.
    Bombardt PA; Brewer JE; Johnson MG
    J Pharmacol Exp Ther; 1994 Apr; 269(1):145-50. PubMed ID: 8169818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of age and gender on the in vitro serum protein binding of flecainide.
    Zordan R; Padrini R; Bernini V; Piovan D; Ferrari M
    Pharmacol Res; 1993; 28(3):259-64. PubMed ID: 8108316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the contribution of alpha 1-acid glycoprotein to the serum binding of basic drugs using serum treated with sulphosalicylic acid and DEAE-cellulose.
    Suzuki Y; Sugiyama Y; Sawada Y; Iga T; Hanano M
    J Pharm Pharmacol; 1985 Oct; 37(10):712-7. PubMed ID: 2867139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The EMIT FreeLevel ultrafiltration technique compared with equilibrium dialysis and ultracentrifugation to determine protein binding of phenytoin.
    Oellerich M; Müller-Vahl H
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():61-70. PubMed ID: 6705428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.